title: Hyperactive hypothalamus, motivated and non-distractible chronic overeating in ADAR2 transgenic mice.
abstract: ADAR2 transgenic mice misexpressing the RNA editing enzyme ADAR2 (Adenosine Deaminase that act on RNA) show characteristics of overeating and experience adult onset obesity. Behavioral patterns and brain changes related to a possible addictive overeating in these transgenic mice were explored as transgenic mice display chronic hyperphagia. ADAR2 transgenic mice were assessed in their food preference and motivation to overeat in a competing reward environment with ad lib access to a running wheel and food. Metabolic activity of brain and peripheral tissue were assessed with [(18) F] fluorodeoxyglucose positron emission tomography (FDG-PET) and RNA expression of feeding related genes, ADAR2, dopamine and opiate receptors from the hypothalamus and striatum were examined. The results indicate that ADAR2 transgenic mice exhibit, (1) a food preference for diets with higher fat content, (2) significantly increased food intake that is non-distractible in a competing reward environment, (3) significantly increased messenger RNA (mRNA) expressions of ADAR2, serotonin 2C receptor (5HT2C R), D1, D2 and mu opioid receptors and no change in corticotropin-releasing hormone mRNAs and significantly reduced ADAR2 protein expression in the hypothalamus, (4) significantly increased D1 receptor and altered bioamines with no change in ADAR2, mu opioid and D2 receptor mRNA expression in the striatum and (5) significantly greater glucose metabolism in the hypothalamus, brain stem, right hippocampus, left and right mid brain regions and suprascapular peripheral tissue than controls. These results suggest that highly motivated and goal-oriented overeating behaviors of ADAR2 transgenic mice are associated with altered feeding, reward-related mRNAs and hyperactive brain mesolimbic region.
authors: Department of Neuroscience, University of Iowa, Iowa City, IA, USA.
authors: A
authors: A
authors: Akubuiro
authors: M
authors: M
authors: Bridget Zimmerman
authors: L L
authors: LL
authors: Boles Ponto
authors: S A
authors: SA
authors: Walsh
authors: J
authors: J
authors: Sunderland
authors: L
authors: L
authors: McCormick
authors: M
authors: M
authors: Singh
mesh_terms: D000243:Adenosine Deaminase / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism; D003346:Corticotropin-Releasing Hormone / Q000235:genetics / Q000378:metabolism; D059305:Diet, High-Fat; D004435:Eating; D005247:Feeding Behavior; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism; D006040:Goals; D006963:Hyperphagia / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology*; D007031:Hypothalamus / Q000378:metabolism / Q000503:physiopathology*; D051379:Mice; D008822:Mice, Transgenic; D049268:Positron-Emission Tomography; D016601:RNA-Binding Proteins; D044405:Receptor, Serotonin, 5-HT2C / Q000235:genetics / Q000378:metabolism; D011954:Receptors, Dopamine / Q000235:genetics / Q000378:metabolism; D017450:Receptors, Opioid, mu / Q000235:genetics / Q000378:metabolism; D012201:Reward; D014158:Transcription, Genetic
chemical_list: D001679:Biogenic Amines; D016601:RNA-Binding Proteins; D044405:Receptor, Serotonin, 5-HT2C; D011954:Receptors, Dopamine; D017450:Receptors, Opioid, mu; D019788:Fluorodeoxyglucose F18; D003346:Corticotropin-Releasing Hormone; C567955:ADARB1 protein, human; D000243:Adenosine Deaminase; D005947:Glucose